Ambiq Micro, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Scott Mclean Hanson, Chief Technology Officer and a Director of Ambiq Micro, Inc., sold 7,000 shares of common stock on September 15, 2026.
NYSE
Ker Zhang, a Director of Ambiq Micro, Inc., sold 10,000 shares of common stock on September 11, 2026.
NYSE
Sean Chihhsiang Chen, President and COO of Ambiq Micro, Inc., sold 15,000 shares of common stock on September 14, 2026.
NYSE
Fumihide Esaka, Chief Executive Officer and a Director of Ambiq Micro, Inc., sold 63,500 shares of common stock on September 11, 2026.
NYSE
Sean Chihhsiang Chen, President and COO of Ambiq Micro, Inc., sold 15,000 shares of common stock on September 4, 2026.
NYSE
Ker Zhang, a Director of Ambiq Micro, Inc., sold 185 shares of common stock on September 4, 2026 for $56.92 per share.
NYSE
Fumihide Esaka, Chief Executive Officer and a Director of Ambiq Micro, Inc., sold 108,500 shares of common stock on August 31, 2026.
NYSE
Scott Mclean Hanson, Chief Technology Officer and a Director of Ambiq Micro, Inc., sold 55,000 shares of common stock on August 26, 2026.
NYSE
Scott Mclean Hanson, Chief Technology Officer and a Director of Ambiq Micro, Inc., sold 7,000 shares of common stock on August 14, 2026.
NYSE
Director Wen Hsuan Hsieh was granted 4,957 restricted stock units as part of the company's 2025 Equity Incentive Plan.
NYSE
Ambiq Micro, Inc. reports a Form 4 filing detailing a restricted stock unit grant to Director Timothy Chen.
NYSE
Ambiq Micro, Inc. reports that Director Bernard Bennett received 4,957 Restricted Stock Units (RSUs) on June 8, 2026.
NYSE
Joseph A. Tautges, a Director at Ambiq Micro, Inc., was granted 4,957 Restricted Stock Units (RSUs) on June 8, 2026.
NYSE
Ambiq Micro, Inc. reports a grant of 4,957 restricted stock units to Director Ker Zhang, vesting over three years.
NYSE
Ambiq Micro CFO Jeffrey Winzeler exercised options to acquire 5,952 shares of common stock.
NYSE
Director Timothy Chen disposed of his entire indirect stake in Ambiq Micro, Inc. through Triumph Way Investment Inc.
NYSE
Director Timothy Chen filed an amendment to a Form 4 to disclose previously omitted conversion of preferred stock into common stock.
NYSE
Ambiq Micro CFO Jeffrey Winzeler exercised options for 31,952 shares and sold a portion of the resulting holdings.
NYSE
Chief Technology Officer Scott McLean exercised stock options and sold shares of Ambiq Micro common stock.
NYSE
President and COO Sean Chihhsiang Chen exercised options for 55,685 shares and sold a portion to cover tax obligations.
NYSE
Ambiq Micro CEO Fumihide Esaka exercised stock options and sold 60,000 shares of common stock.
NYSE
Michele Kim Connors, General Counsel of Ambiq Micro, Inc., reported the sale of company shares to cover tax obligations related to vested restricted stock units.
NYSE
Ambiq Micro's CFO, Jeffrey G. Winzeler, reported a grant of 41,728 Restricted Stock Units (RSUs) and an adjustment to previously reported ownership, with vesting commencing October 1, 2027.
NYSE
Sean Chen, President and COO of Ambiq Micro, Inc., reported a transaction involving the acquisition of 64,246 restricted stock units.
NYSE
Ambiq Micro, Inc. reports a significant grant of restricted stock units to Chief Technology Officer Scott Hanson, with vesting scheduled over several years.
NYSE
Ambiq Micro CEO Fumihide Esaka acquired restricted stock units (RSUs) as part of his compensation, with vesting scheduled to begin in October 2027.
NYSE
Ambiq Micro filed an amendment to a Form 4 to correct the vesting commencement date for a restricted stock unit grant to its General Counsel.
NYSE
Ambiq Micro's CEO, Fumihide Esaka, exercised stock options to acquire 53,660 shares of common stock at $5.88 per share, reported significantly late.
NYSE
Ambiq Micro Director Joseph A. Tautges sold 7,800 shares of common stock at $31 per share, reducing his direct beneficial ownership to 48,746 shares.
NYSE
Ambiq Micro's Chief Technology Officer, Scott McLean Hanson, reported the sale of 10,000 shares of common stock at $31 per share, executed under a Rule 10b5-1 plan.